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Background: Recent epidemics of dengue viruses (DENV) coupled with new outbreaks on the horizon have
renewed the demand for novel detection methods that have the ability to identify this viral pathogen prior to the
manifestation of symptoms. The ability to detect DENV in a timely manner is essential for rapid recovery from
disease symptoms. A modified lab-derived 10-23 DNAzyme tethered to gold nanoparticles provides a powerful tool
for the detection of viruses, such as DENV.
Results: We examined the effectiveness of coupling DNAzyme (DDZ) activation to the salt-induced aggregation of
gold nanoparticles (AuNP) to detect dengue virus (DENV) progeny in mosquito cells. A DNAzyme was designed to
recognize the 5’ cyclization sequence (5’ CS) that is conserved among all DENV, and conjugated to AuNPs.
DDZ-AuNP has demonstrated the ability to detect the genomic RNA of our model dengue strain, DENV-2 NGC,
isolated from infected Aedes albopictus C6/36 cells. These targeting events lead to the rapid aggregation of AuNPs,
resulting in a red to clear color transition of the reaction mixes, and thus positive detection of the DENV RNA
genome. The inclusion of SDS in the reaction mixture permitted the detection of DENV directly from cell culture
supernatants without additional sample processing. Specificity assays demonstrated detection is DENV-specific,
while sensitivity assays confirm detection at levels of 1 × 101 TCID50 units. These results demonstrate DDZ-AuNP
effectively detects DENV genomes in a sequence specific manner and at concentrations that are practical for field
use.
Conclusions: We have developed an effective detection assay using DNAzyme catalysis coupled with AuNP
aggregation for the detection of DENV genomes in a sequence specific manner. Full development of our novel
DDZ-AuNP detection method will provide a practical, rapid, and low cost alternative for the detection of DENV in
mosquito cells and tissues, and possibly infected patient serum, in a matter of minutes with little to no specialized
training required.
Keywords: Dengue, Flavivirus, DNAzyme, Nanoparticles, Gold, Arbovirus, DetectionBackground
Dengue viruses (DENV), members of the Flavivirus family
of viruses, cause periodic explosive epidemics in many
tropical and sub-tropical countries leading to approxi-
mately 50-100 million infections per year [1-5]. Approxi-
mately 500,000 of these are severe cases requiring
hospitalization with a 2.5% fatality rate, most of which are
children [1-5]. Approximately half the world’s population* Correspondence: jcarte11@nd.edu
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reproduction in any medium, provided the orremains at risk for DENV infection making this pathogen
one of the most dangerous viruses in the world [6]. In
2010 there were 1.6 million cases of Dengue in the
Americas alone, of which 49,000 were severe cases [1]. Re-
cent domestic outbreaks have occurred in the Hawaiian
Islands in 2001 [7], Brownsville, Texas in 2005 [8], the
Florida Keys in 2010 [9] and other parts of southern Florida
including Miami-Dade in 2011 [10,11]. Furthermore,
devastating outbreaks continue to occur in Puerto Rico
[10,12,13], Brazil [14], and Pakistan [15], to name a few.
DENV are maintained in a cycle that involves humans
and the globally disseminated Aedes aegypti mosquito [16].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Overview of the DDZ-AuNP assay for dengue virus
detection. Schematic of the DENV detection system using DENV-
specific DNAzyme (DDZ) catalysis coupled with gold nanoparticle
(AuNP) aggregation. AuNPs are conjugated with the sulfide-linked
anti-DENV DNAzyme, DDZ, which is complimentary to the DENV
RNA genome (shown in orange). Black vertical lines indicate
complimentary base pairing between DDZ and the target RNA. In
the presence of DENV RNA (A), the 5’ and 3’ arms of the anti-DENV
DNAzyme, DDZ, bind to the 3’ and 5’ ends of the targeted 5’-3’ CS
region, respectively (B). When Mg2+ and heat (37°C) are introduced
DDZ digests the viral RNA (C). This digestion results in deshielding
of the AuNP, leading to aggregation of these AuNPs in the presence
of NaCl and heat (D) allowing a rapid and visually detectable red to
clear color transition (E). This color transition signifies the successful
detection of DENV, and can be quantified by UV/Vis
spectrophotometry at 520 nm AuNPs = red, tethered DNA probe =
orange, DENV genome = purple.
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ically related DENV serotypes (designated DENV-1, -2, -3,
and -4) can result in dengue fever (DF) and/or potentially
fatal dengue hemorrhagic fever (DHF) [17]. These disease
states are characterized by high fever, often with enlarge-
ment of the liver, and in severe cases circulatory and
respiratory failure [3]. While DF and DHF are endemic to
tropical and subtropical regions of the world, collapse of
effective vector control programs, rapid dispersal of
viruses due to ease of global travel, and migration of
humans from tropical to non-tropical regions has resulted
in DENV outbreaks in regions that were once non-
endemic to these viral pathogens.
The ability to detect DENV in a timely manner is es-
sential to rapid recovery from disease symptoms. Cur-
rently, detection of mosquito-borne viruses in infected
persons is limited to plaque assays, antigen detection as-
says (e.g. NS1 antigen detection), or quantitation of viral
production through PCR-based methods [18-20]. These
assays are currently referred to as the “gold standards”
for DENV detection [21-24]. More relevant to our re-
search, current testing of mosquito populations for arbo-
viruses in general, but more specifically dengue viruses,
has been limited to RT-PCR of mosquito pools (25-100
insects) [25-27].
The approaches mentioned above are limited by a number
of pitfalls including low-throughput, labor-intensiveness, low
stability of assay components at or above room tem-
perature, and lack of portability. The requirement for spe-
cialized training and equipment and the time consuming
nature of these assays limits their widespread utility for
virus detection. These limitations compromise rapid diag-
nosis of viral infections. Additionally, these methods are
not easily adapted to field environments where reliable
and effective detection methods are needed. Rapid, low-
tech virus detection methods that require no specialized
training or education are sorely needed to provide remote
areas of the world the ability to detect highly pathogenic
viruses for both clinical diagnosis and epidemiological
surveillance.
In this report we describe the development and initial
validation of a colorimetric DENV detection method
that couples the RNA targeting ability of a DENV-
specific DNAzyme (DDZ) with the aggregation proper-
ties of oligonucleotide-tethered, noncrosslinking gold
nanoparticles (AuNPs). Our innovative DENV detection
system, called DDZ-AuNP (Figure 1), should be an in-
valuable tool for the detection of DENV since it solves
many of the limitations of current virus detection assays.
This assay and subsequent analysis is cost effective, sim-
ple to perform, and the assay components are highly
stable at temperatures above 30°C enabling easy storage
at room temperature. The use of DNAzymes in the assay
increases the specificity and versatility of detectionpermitting the design and incorporation of additional
virus or strain-specific DNAzymes and probes.
Full development of this detection assay would greatly
enhance virus diagnostics and epidemiology by providing
an assay that is more rapid, easier to use, has greater
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DENV detection methods.
Results
Overview of the colorimetric detection of DENV by
DNAzyme activity coupled with noncrosslinking AuNP
aggregation (DDZ-AuNP)
The dengue virus detection method described below
(see Figure 1) is based upon RNA aptazyme-mediated
detection of small molecules, such as theophylline
[28,29]. The central limitation of using RNAzymes and
aptazymes for virus detection is the inherent instability
these catalytic RNAs, increasing the attractiveness of
DNAzymes in detection assays.
The colorimetric detection of DENV by DDZ-AuNP
can be divided into three phases: targeting/cleavage of
the DENV RNA genome by DDZ, activation of AuNPs,
and aggregation of AuNPs and detection (Figure 1). In
the presence of DENV the 5’ and 3’ arms of DDZ bindFigure 2 Anatomy of the 10-23 anti-DENV DNAzyme (DDZ) and Schem
produced as previously described [36,85] and in Materials and Methods. R =
DNAzyme 10-23 shown in black. The 5’ and 3’ ends of target RNA and DNA
base pairing. Arrows indicate cleavage site of the target RNA. B) A represen
genome is shown to illustrate the position of the region targeted by the a
shown in green. Structural genes encoding capsid, membrane glycoprotein
untranslated region, PA = polyadenylation.to the 3’ and 5’ ends of a fully conserved segment that
includes the 5’-3’ CS region, respectively, and in the
presence of Mg2+ and heat (37°C) the viral RNA is
cleaved at G149. This cleavage results in deshielding and
aggregation of the AuNPs in the presence of NaCl and
heat [30-32], causing a visually detectable red to clear
color transition [31,32] that can be quantified by UV/Vis
spectrophotometry at 520 nm [31,32]. If DENV are not
present in the sample, the DNAzyme -tethered AuNPs
remain in a dispersed state and no color loss should
occur [31,32]. Likewise, if any of the essential compo-
nents such as magnesium or sodium are not present in
the reaction mixture, no aggregation is possible.
Design and in vitro cleavage assessment of the DENV
detection system DDZ-AuNP
DNAzymes are lab-derived, auto catalytic DNAs consisting
of three intimately connected domains (Figure 2A): A cata-
lytic core that is activated by binding a cofactor (eg. Pb2+ oratic Diagram of the DENV genome. A) DDZ was designed and
Purine. Y = Pyrimidine. The target RNA is in green with the anti DENV
zymes are as indicated. Thin black vertical lines show complimentary
tation of the 10,723 base DENV-2 NGC GC capped and polyadenylated
nti-DENV DNAzyme, DDZ. Non structural (NS) genes 1 through 5 are
precursor, and envelope proteins are shown in red. UTR =
Figure 3 In vitro DDZ activity assay. DDZ-M-AuNPs (1 × 105
particles/mL) were placed in a buffered solution containing 10 mM
MgCl2, DENV-2 NGC RNAs (0.6 μM) isolated from Ae. albopictus C6/
36. Following incubation at 37°C for 30 minutes, RT-PCR was
performed as described in Materials and Methods to amplify
digestion products. Fragments were then separated on a 1.75% TAE
agarose gel in the presence of ethidium bromide and
photographed under UV light. Arrows indicate digestion products of
approximately 150 and 350 bases and the primer dimer, respectively.
Results demonstrate DDZ-M digestion of full length DENV-2 genome
in spite of AuNP conjugation. DDZ = anti-dengue virus DNAzyme,
DDZin = inactive anti-dengue virus DNAzyme.
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cofactor) [37], and 5’ and 3’ binding arms that bind to the
3’ and 5’ regions of the target sequence, respectively.
DNAzymes have demonstrated impressive sensitivity in
detecting metal ions or RNA [38-45].
The 10-23 DNAzyme is capable of cleaving RNA with
high sequence specificity at target sites containing purine-
pyrimidine (R-Y) junctions [46]. We chose the 10-23
DNAzyme for use in our DENV detection system because
this DNAzyme is less dependent on secondary structure
formation for its activity than other DNAzymes [47] and
would be expected to perform better in our in vitro assays
where biomolecular folding would be quite variable. The
design of the anti-DENV 10-23 DNAzyme, DDZ-M
(Figure 2A), was based on a 10-23 DNAzyme clone that
was discovered through SELEX (Systematic Evolution of
Ligands by Exponential Enrichment). We designed the 5’
and 3’ arms to target the highly conserved region that in-
cludes the 5’-3’ cyclization sequence (CS) that is present in
all DENV serotypes, and is required for replication of gen-
omic RNA (Figure 2A) [48,49].
Gold nanoparticles (AuNPs) ranging from 15 nm to
100 nm in diameter have been used in a number of de-
tection assays [30,50,51]. We chose to conjugate DDZ to
15 nm AuNPs since fewer copies of single-stranded
DNA are required to cover the surface of a 15 nm AuNP
than any AuNP of larger size [52], and interaction of
only 7.5% of DNAs conjugated to the 15 nm AuNPs
with the substrate RNA is required to initiate aggrega-
tion of the AuNPs [30].
AuNP-conjugated DDZs were analyzed for their ability
to cleave the DENV-2 NGC RNA in vitro. DENV-2 NGC
viral RNAs were isolated from infected Ae. albopictus C6/
36 cells, and incubated in a buffered solution containing
1 × 105 DDZ-M-tethered AuNPs/mL for 30 minutes at
37°C. Digestion products were then amplified by RT-PCR
using heterologous and hexamer primers designed to aid
in the amplification of DDZ digestion products.
Successful digestion of the DENV-2 NGC RNA genome
by DDZ-M was demonstrated by the positive detection of 2
fragments of approximately 150 and 350 bases in size, indi-
cative of DDZ-M catalysis (Figure 3). DNAzyme catalytic
activity against the DENV-2 RNA genome was validated by
the inclusion of an inactive DNAzyme negative control,
DDZin-M, that was created by inverting the catalytic do-
main which has been previously shown to render the
DNAzyme catalytically inactive [41]. As expected, the cata-
lytically inactive DDZin-M did not digest the DENV-2
NGC genome due to this alteration in the catalytic domain.
Addition of an artificial DENV-2 RNA target initiates
aggregation of DDZ tethered AuNPs
As an initial test of the utility of our colorimetric detection
method a synthetic target was designed and synthesizedthat corresponds to the 5’ 170 bases of the DENV-2 NGC
genome. This stretch of nucleotides included the highly
conserved 5’ CS domain and the initial 74 bases of the
capsid gene [49,53,54].
Synthetic target (7.5nM) was added to a buffered mix-
ture containing 1 × 105 DDZ-AuNPs/mL, 10 mM MgCl2
and1.0 M NaCl (Figure 4) as previously described [31,32].
The control mix contained the same components except
50 mM Tris HCl was substituted for the synthetic DENV-
2 target. Reaction mixes were incubated at 37°C to initiate
the detection reaction. Aggregation of the DDZ-M–teth-
ered AuNPs, observed by a red to clear color transition,
was evident within the first 5 minutes of incubation. This
aggregation event occurred only in the presence of the
synthetic DENV-2 RNA, and therefore demonstrated a
positive test for the presence of DENV-2 RNA.
Optimization of NaCl concentration
Sodium, in the form of NaCl, is an essential component
of AuNP colorimetric detection assays because this
monovalent salt drives aggregation of oligonucleotide-
conjugated AuNPs [30,55-57] following the interaction
of the AuNP conjugated probes with complimentary
Figure 4 Colorimetric DDZ-AuNP detection of a synthetic
DENV-2 NGC RNA target. A synthetic stretch of ribonucleotides
corresponding to the 5’ 170 bases of the DENV-2 RNA genome was
added to a buffered mixture containing 10 mM MgCl2, 1 × 10
5 DDZ-
M-AuNP particles/mL, and 1.0 M NaCl. Samples were incubated at
37°C for 5 minutes and photographs were taken. Control samples
were treated the same as experimental except 50 mM Tris–HCl was
added in lieu of the synthetic DENV-2 RNA. Aggregation of DDZ-M
tethered AuNPs only occurred in the presence of synthetic DENV
RNA. Results indicate that DDZ-AuNPs have the ability to detect
DENV. DDZ = anti-DENV DNAzyme.
Figure 5 Determination of optimal NaCl and SDS concentrations. A) T
aggregation of DDZ-M-AuNP following interaction with the DENV-2 RNA g
isolated as described in Materials and Methods and 0.6 μM was incubated
10 mM MgCl2, and increasing concentrations of NaCl (0 to 2 M) for 30 min
shown. The concentration of NaCl is indicated above each reaction tube. A
the DENV-2 NGC genome. 1.5 M NaCl was determined to be the minimal o
reactions. B) The optimal concentration of SDS was determined in the pres
NGC (MOI = 0.1). At 6dpi, 10 μl of cell supernatants containing 1 × 106 DEN
mix containing 10 mM MgCl2, 1 × 10
5 DDZ-M-AuNP particles/mL, 1.5 M Na
at 37°C for 30 minutes and photographs were taken. Results demonstrate t
optimally in 0.5% SDS. The percent SDS used is indicated above each eppe
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tions greater than 2 M can cause instability of conjugated
AuNPs [30]. Furthermore, published reports indicate that
NaCl concentrations for effective AuNP aggregation can
vary from 1.0 M to 1.5 M [51,60]. In light of these prior
observations, we evaluated the optimal NaCl concentra-
tion necessary to initiate aggregation of DDZ-M-AuNP
following interaction with the DENV-2 genome.
DENV genomic RNAs (~0.6 μM), isolated from infected
C6/36 cell supernatants, were added to a buffered reaction
mixture containing DDZ-M–AuNP (~1 × 105 particles/
mL), 10 mM MgCl2 and NaCl at concentrations ranging
from 0 M to 2 M (Figure 5A). Samples were incubated
at 37°C for 30 min. A red to clear color transition
confirming optimal detection of the DENV genome was
observed in as little as 5 minutes in the presence of
1.5 M NaCl. The 0 M NaCl control provided confirm-
ation that the red to clear color transitions observed
were not the result of destabilization of aggregates from
DNAzyme activity against the AuNPs, nor were they
caused by non-specific interaction of the DNAzymeshe optimal concentration of sodium, in the form of NaCl, for
enome was determined. DENV -2 NGC strain genomic RNAs were
in a reaction mix containing DDZ-M-AuNP (1 × 105 particles/mL),
utes at 37°C. A representative photograph of the reaction tubes is
full red to clear color transition indicates the optimum detection of
ptimum concentration of NaCl to use in our DENV detection
ence of DENV-2 NGC virions. C6/36 cells were infected with DENV-2-
V-2 NGC/mL, as determined by TCID50-IFA, were added to a reaction
Cl, and 0% (w/v) to 1% (w/v) SDS detergent. Samples were incubated
hat the DDZ-M-AuNP colorimetric method for DENV detection occurs
ndorff tube. SDS = sodium dodecyl sulfate.
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onstrate the high stability and utility of our DDZ -AuNP
assay at temperatures greater than 30°C, a critical criterion
for any DENV detection assay [61].Determination of the optimal SDS concentration for
colorimetric DDZ-AuNP detection of DENV
Our DDZ-AuNP assay system demonstrated utility in
detecting purified DENV-2 RNAs. However, to improve
this assay for field use we needed a protocol that has
speed, efficacy, and simplicity in detecting DENV RNA
directly from virions. Liberating the DENV RNA genome
from virion particles using a low cost, non-toxic RNA ex-
traction reagent that is stable in the reaction buffer and
does not interfere with the assay would be ideal. Sodium
dodecyl sulfate (SDS) is an effective non-ionic detergent
for lysing virus particles [62]. SDS may be considered an
ideal component for our colorimetric detection assays be-
cause it is non-toxic, stable in the reaction buffer, and does
not require additional manipulation during lysis.
The optimal concentration of SDS was determined by
adding cellular supernatants containing 1 × 106 DENV-2/mL
to buffered reaction mixes containing DDZ -tethered
AuNPs (DDZ-AuNP), 10 mM MgCl2 and SDS at
concentrations of 0% (w/v), 0.5% (w/v) or 1.0% (w/v)
(Figure 5B). Detection of DENV-2 NGC RNAs from cell
culture fluid was not possible in the absence of SDS fol-
lowing incubation at 37°C for 30 min. Similarly, controls
involving mock infected cell supernatants with or with-
out SDS showed no red to clear color change distinctive
of AuNP aggregation. However, infected cell culture su-
pernatants displayed positive detection in as little as 5 mi-
nutes, and only in the presence of SDS and DENV-2
NGC. AuNP aggregation in the presence of 0.5% SDS and
absence of DENV-2 virus particles was undetectable.Figure 6 Assessing Mg2+ resistance of DDZ-tethered AuNPs.
DDZ-M tethered AuNPs were incubated with increasing
concentrations of MgCl2 (0 to 20 mM) as described in Methods.
Following a 30 minute incubation period at room temperature (~25°C),
UV/Vis spectrophotometry and photography were performed. These
results demonstrate that DNAzyme conjugated AuNP aggregation is
not driven by 10 mM MgCl2, which is used in all detection assays
described in this report.Measurement of Mg2+ resistance of oligonucleotide-
tethered AuNPs
Since DDZ is activated by 10 mM MgCl2, we needed to
confirm that the positive detection of DENV-2 was due to
specific recognition of the viral genome by DDZ-M-AuNP
and not the result of a false positive from Mg2+ ion
destabilization of DDZ-AuNPs [30,55-57]. The stability of
DDZ-M-AuNP was tested against increasing concentra-
tions of MgCl2 (0 mM to 20 mM) at room temperature
every 5 minutes for up to 30 minutes (Figure 6), and ab-
sorbencies were measured with a NanoDrop spectropho-
tometer at 520 nm. As expected, concentrations equal to or
less than 10 mM MgCl2 did not display a detectable effect
on the stability of the oligonucleotides-tethered AuNPs as
evidenced by a lack of aggregation and absorbance, while
those above 10 mM resulted in rapid instability of DDZ-AuNP, leading to aggregation of the nanoparticles as
evidenced by the rapid decrease in absorbance.
Specificity of DDZ-AuNP for DENV
Because Chikungunya virus (CHIKV) and DENV co-
infections have become more prevalent in South Asia
and Africa [63-65], we tested our DDZ-AuNP detection
method for its specificity for DENV in the presence of
CHIKV (Figure 7A). Cellular supernatants containing
1 × 106 DENV-2 or 1 × 106 CHIKV/mL, as determined
by TCID50-IFA [53,66] (1 TCID50 unit = 0.7 virus plaque
forming units (pfu)) were added to a buffered reaction
mixture containing 1 × 105 DDZ-M or DDZin-Mtethered
AuNP/mL, 10 mM MgCl2, 1.5 M NaCl and 0.5% (w/v)
SDS. As expected when gold nanoparticles tethered with
DDZ-M DNAzymes were incubated with either mock
infected or CHIKV infected cell supernatants, AuNP ag-
gregation did not occur. Furthermore, the substitution of
DDZ-M-AuNP with the negative control DDZin-M-
AuNPs also resulted in negative detection of DENV. How-
ever, positive detection of DENV-2 NGC was observed in
as little as 5 minutes, when DDZ-M-AuNP was incubated
with DENV in fected C6/36 cell derived supernatants.
These results demonstrated DDZ-M-AuNP could specifically
detect DENV in these mixed virus samples.
An important feature of using gold nanoparticles in
colorimetric detection schemes is that the aggregation of
AuNPs can be detected by UV/Vis spectroscopy. Since the
absorption maximum of the 15 nm AuNPs used in this
detection method is 520 nm, a decrease in absorbance at
520 nm can also be used to detect and quantitate aggre-
gation. This was tested using reaction mixtures containing
cell culture supernatants from DENV infected cells
(Figure 7B). UV/Vis spectrophotometric analysis at A520
showed a decrease in absorbance when DDZ-M-AuNP
Figure 7 Assessment of DDZ-AuNP specificity. A) DENV-2 and CHIKV (1 × 106/mL each) were placed in a buffered solution containing 10 mM
MgCl2, 1 × 105 DDZ-AuNP particles/mL, 1.5 M NaCl, and 0.5% (w/v) SDS. Eppendorf tubes containing these mixes were incubated at 37°C for 30
minutes and photographed. CHIKV = chikungunya virus. DENV-2 = dengue virus serotype 2, DDZ-M = anti-dengue virus DNAzyme, DDZin-M =
inactive anti-dengue virus DNAzyme. B) Analysis of DENV detection by UV/Vis Spectrophotometry. Samples were assembled as was performed for
in A, mixed, incubated at 37°C for 5 minutes, and spectrophotometric analysis was performed using the ND-1000 spectrophotometer. C)
Detection of DENV by DDZ-M-AuNP in comparison to several other flaviviruses. The specificity of our DDZ-M-AuNP device to detect DENV and
not other fellow flavivirus members YFV, JEV or ZV was determined as described earlier (see Figure 4). D) An alignment was performed on
consensus sequences of each of the four DENV serotypes to determine the most optimal regions for the design of serotype specific DDZ-AuNP
devices by determining the region of least conservation one serotype has with the other DENV serotypes. E) Colorimetric serotype-specific
detection of DENV. Cell culture supernatants from C6/36 cells mock infected (Mock), or from cells infected with either DENV serotypes 1 through
4 or CHIKV (1 × 106/mL each) were placed in buffered solutions containing the necessary cofactors and AuNPs tethered with our all purpose
DENV serotype specific DNAzyme, DDZ-M, or one of the serotype-specific DDZs (designated DDZ-1 through-4) designed to specifically target the
corresponding DENV serotype (Table 1). Eppendorf tubes containing these mixes were incubated at 37°C for 5 minutes and photographed.
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quantitate these aggregation events. Mock or CHIKV
infected cell culture fluids, or AuNPs tethered with the
catalytically inactive DDZin-M do not elicit a detectible
change in absorbance. These results show that our colori-
metric DDZ-AuNP method for DENV detection possesses
utility in a UV/Vis spectrophotometric platform.
DENV shares similar symptoms with other closely related
mosquito-borne flaviviruses, such as Yellow Fever (YFV)
[67,68], Japanese Encephalitis (JEV) [69], and Zika (ZV)
[70,71] viruses. These viruses also co-circulate with DENV
and are often misdiagnosed as dengue. Therefore, a DENV
detection method must demonstrate the ability to distin-
guish DENV, from other mosquito-borne flaviviruses.
Although the 5’-3’ CS domains are largely (but not fully)conserved among flaviviruses, the entire DDZ-M bind-
ing site is not conserved among all these flaviviruses as
demonstrated by a sequence alignment of our DDZ-M
binding site with corresponding regions in YFV, JEV,
and ZV viruses. We also performed a experimental ana-
lysis of our DDZ-M-AuNP assay to verify its ability to
distinguish DENV over other flaviviruses. Separate reac-
tion mixtures were assembled as previously described
(see Figure 4), except that artificial RNA substrates
comprised of the 5’ 220 nucleotides of the YFV, JEV, ZV,
and DENV genomes were used as targets (Figure 7C).
This stretch of nucleotides included the highly conserved
5’ CS domain and the initial 74 bases of the capsid genes
of each flavivirus. Aggregation of the DDZ-M-tethered
AuNPs was evident only in the presence of the artificial
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tethered with the catalytically inactive DDZin-M did not
aggregate in the presence of any flavivirus RNA substrate
tested illustrating that mere binding of an RNA substrate
is not enough to elicit an aggregation response by AuNPs.
These results further validated the specificity of our
DENV detection method.
Lastly, to be effective in epidemiological surveillance
efforts, a DENV detection method must demonstrate
the ability to detect each serotype independently of the
other. An alignment of all four known DENV serotypes
was performed to determine the ideal target sites for the
design of serotype specific DNAzymes (Figure 7D) and ap-
propriate targeting sequences were assembled (Table 1).
Serotype- DNAzyme-tethered AuNPs were tested for their
ability to detect viral genomic RNAs of DENV serotypes 1
through 4 (Figure 7E). AuNPs-tethered with either a
serotype-specific DDZ or the multiple serotype detecting
DDZ-M were placed in separate mixtures containing the
DENV serotype indicated, 0.1% SDS to lyse virus particles,
and 1.5 M NaCl (Figure 7E). Mixes were incubated at
37°C for 5 min.
The DENV-1 serotype-specific DDZ-1-AuNP positively
detected the DENV-1 serotype as signified by a distinctive
red to clear/colorless color transition. As expected, DDZ-
1-AuNP did not detect DENV-2, -3, or -4, illustrating the
serotype-specific nature of this approach (Figure 7E). Like-
wise, each of the other serotype specific DNAzyme teth-
ered AuNPs detected only the corresponding DENV
serotype (Figure 7E and Table 1). These results demon-
strated a DENV detection method that couples DNAzyme
activity with AuNP aggregation to identify DENV in a
serotype-specific manner. Cell culture supernatants con-
taining the negative control CHIKV were added in lieu of





DENV-1 DENV-2 DENV-3 DENV-4
DDZ-M-AuNP All Serotypes + + + +
DDZ-1-AuNP DENV-1 + - - -
DDZ-2-AuNP DENV-2 - + - -
DDZ-3-AuNP DENV-3 - - + -
DDZ-4-AuNP DENV-4 - - - +
Negative Control
DDZin-M-AuNP None - - - -
Left column lists the active (DDZ-M-AuNP and DDZ-1-AuNP through DDZ-4-
AuNP) and inactive negative control (DDZin-M-AuNP) devices used in this
report. The second column lists the serotype each device was designed to
detect. Lastly, the right column lists the summarized results of the DENV
detection devices and the negative control DDZin-M-AuNP. See Methods for
description of DNAzyme design.serotype specific AuNPs and overall feasibility of our
DENV detection assay. As expected, neither mock
infected nor CHIKV infected cell culture supernatants
yielded the red to clear color transition typically observed
for the positive detection of DENV, showing our conju-
gated AuNPs were not influenced by cell or CHIKV de-
rived oligonucleotides.
The limits of DDZ-AuNP colorimetric detection of DENV-2
The sensitivity of our DENV detection system was
assessed using standardized titers of DENV-2 (Figure 8).
Titers of 101, 102,104 and 106 viruses/ml, as determined
by TCID50-IFA (data not shown), were assayed using
our colorimetric DDZ-M-AuNP detection method as de-
scribed above. The negative controls consisted of the
same reaction mixture as the experimentals lacking
DENV-2 (mock), or with the catalytically inactive DDZin-
M substituted for DDZ-M. Following the addition of
1.5 M NaCl and incubation at 37°C for 5 minutes samples
were analyzed by visual inspection.
Positive DENV-2 detection was evident after only 5 mi-
nutes at 37°C, and demonstrated as little as 101 DENV/
ml could cause a color transition, although the samples
containing 101 and 102 did not transition to a very pale
purple rather than completely clear. In addition, we cal-
culated the amount of DENV RNA corresponds to ap-
proximately 0.6 μM (for 106/ml), 6 nm (for 104/ml),
0.6nM (for 102/ml), or 0.06 nM (for 101/ml) of DENV
RNA per reaction.
Further assessment of the sensitivity of our colorimet-
ric DENV detection assay was further assessed by UV/
Vis spectrophotometry using standardized titers of
DENV-2 (Figure 8B). Titers of 101, 102, and 106, viruses/
ml, as determined by TCID50-IFA (data not shown) and
five serial dilutions originating from 101 (Dil1 through
Dil5) were assayed using our colorimetric DDZ-M-AuNP
as described in methods, and analyzed by UV/Vis spectro-
photometry at an absorbance of 520. Positive detection of
DENV-2 was evident with each sample that contained
DENV-2 RNA, as demonstrated by a decrease in A520.
This result is displayed as a greater –log10(520) value than
the negative control Mock or CHIKV infected samples.
Logarithmic interpretation of the resulting spectro-
photometric measurements was performed to derive
detection assay sensitivity. A linear relationship (R2 =
0.92; Figure 8B) demonstrates this assay is both sensitive
and accurate. Spectrophotometric results also demonstrate
our colorimetric DENV detection assay possesses the sen-
sitivity to detect the presence of the DENV genome, even
in very dilute samples (Dil4) which is of no surprise since
researchers have previously detected colorimetric change
associated with AuNP aggregation, by spectrophotometry,
in samples containing only femtomole amounts of sub-
strate [72,73].
Figure 8 Analysis of DDZ-AuNP sensitivity. A) DDZ-M-AuNP colorimetric assays were performed on DENV-2 NGC titers of 1 × 101, 1 × 102,
1 × 104, and 1 × 106 to determine the limits of detection. Samples were assembled as described in Methods, incubated at 37°C for 30 minutes
and photographed. Results show that the DDZ-M-AuNP colorimetric assay is capable of detecting DENV-2 at a titer as low as 1 × 101.
DDZ-M = anti-dengue virus DNAzyme, DDZin-M = inactive anti-dengue virus DNAzyme. B) Analysis of DDZ-AuNP sensitivity by UV/Vis
spectrophotometry. Ten microliters (10 uL) of cell culture fluid from Mock, DENV-2 NGC (titers of 1 × 101, 1 × 102 1 × 106/mL), or CHIKV vaccine
strain 181/25 (1 × 106/mL) infected C6/36 cells, or DENV serially diluted from 1 × 101 (Dil1 through Dil5) or were added to separate mixtures as
described in A). UV/Vis spectrophotometric analysis was performed using the ND-1000 spectrophotometer at an absorbance of 520 nm.
Absorbance measurements were graphed in log scale to illustrate sensitivity and accuracy of the colorimetric DENV detection method.
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Simple and rapid diagnostic methods to screen mosquito
and patient samples for the presence of viral pathogens
can significantly facilitate diagnosis and treatment of
virus borne diseases in field environments where sophis-
ticated methods of virus detection are impractical. An
ideal virus detection method must distinguish the target
pathogen from other diseases exhibiting similar symp-
toms (such as malaria, leptospirosis, typhoid, typhus and
Chikungunya), be highly sensitive during the acute stage
of infection, provide rapid results, be inexpensive, easy
to use, and stable at temperatures greater than 30°C for
use in a field environment [61]. Furthermore, DENV de-
tection methods must show utility in epidemiological
surveillance and outbreak monitoring by allowing inde-
pendent detection of each serotype, and must have the
ability to distinguish between primary and secondary in-
fection [61].
In light of the caveats and pitfalls of the virus detec-
tion methods currently in use [18-24,45], the aim of this
research was to explore the utility of a multiple DENVserotype targeting DNAzyme, called DDZ-M, and
DENV- serotype specific DNAzymes (Table 1), coupled
to AuNPs for detecting DENV. DDZ was designed to
target the most conserved region of the DENV genome
that includes the 5’-3’CS (Figure 2A and 2B). DENV sero-
type-specific DNAzymes (designated DDZ-1 through
DDZ-4) were engineered to bind regions of DENV that
are conserved within each serotype. The demonstrated
ability of DNAzymes to successfully target small stretches
of RNA makes these catalytic oligonucleotides highly
useful for targeting conserved regions of virus genomes.
Our results suggest that DNAzyme targeting coupled
with noncrosslinking AuNP aggregation satisfies many
of the criteria required to have an ideal method for
DENV detection.
While our DDZ-AuNP colorimetric detection system
demonstrates the capacity to target the highly conserved
DENV 5’ CS region, the utility of these molecules as de-
tection agents requires a minimal subset of anti-DENV
DNAzymes (DDZs) to be occupied for aggregation of
AuNPs to occur. The high tolerance of DNAzymes to
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[74,75] makes DNAzymes ideal for detection of viruses
because they will be able to detect many closely related
variants. Prior studies have demonstrated aptazymes can
detect synthetically produced segments of virus genomes
[45]. We have demonstrated that under optimal reaction
conditions the full length genome of DENV-2 can also
be detected through the aggregation of DDZ-tethered
AuNPs following the interaction of the DDZ component
with the DENV-2 RNA genome.
Our anti-DENV DNAzyme (DDZ), when conjugated
with AuNPs, readily detects its cognate target sequence
within a synthetic 170 base segment of the DENV-2
NGC RNA corresponding to the 5’UTR, 5’CS and the 5’
74 bases of the capsid open reading frame (Figure 4).
Aggregation events result from deshielding AuNPs from
sodium ions following DDZ binding to the synthesized
DENV-2 target [76]. The DDZ-AuNP conjugate also de-
tects purified viral RNAs or genomic RNA liberated
from cell culture derived DENV-2 NGC virions. In our
analyses we utilized cell culture supernatants instead of
patient blood sample or infected mosquitoes because it
is more convenient to determine optimal experimenta-
tion parameters (e.g. SDS and NaCl concentrations
(Figure 5A and 5B, respectively) and limits of detection
(Figure 8) using a less complex cell culture system.
These results provide the first confirmation of effective
DENV detection using our DDZ-AuNP assay, and repre-
sent for the first time a catalytic nucleotide-based
method can be used to detect DENV in fluid. Subse-
quent analyses will be required to optimize procedures
for applications with infected patient serum or mosquito
tissues.
Previous studies using oligonucleotide-tethered AuNPs
have determined optimal aggregation occurs with NaCl
concentrations from 1.0 M to 1.5 M, while concentra-
tions ≥ 2.0 M destabilized conjugated AuNPs [30]. In our
hands, a NaCl concentration of 1.5 M allows full aggre-
gation of DDZ-AuNP in the presence of 0.6 μM DENV-
2 RNA (Figure 5A). We may infer that the color transi-
tion observed in samples containing DENV was not due
to DNAzyme activity against the AuNP or non-specific
interaction with cell derived oligonucleotides since the
control solution containing 0 M NaCl did not yield a
false positive result.
Furthermore, DDZ-AuNP aggregation in our DENV de-
tection assays was not driven by the loss of AuNP stability
in the presence of 10 mM MgCl2 (Figure 6). This was not
a surprising result since resistance of DNA-probe-tethered
AuNPs to MgCl2 concentrations ≤ 10 mM have been
reported [30,51].
Sodium dodecyl sulfate (SDS) proved to be an effect-
ive, low cost, detergent for directly lysing virus particles
in our assay [62]. SDS titration experiments on cellculture fluids containing DENV-2 NGC (Figure 5A).
demonstrated a concentration of 0.5% (w/v) was suffi-
cient to completely lyse DENV-2 particles without inter-
fering with AuNP aggregation reactions. Addition of this
detergent to the assay components has no effect on the
cleavage or aggregation reactions.
Our DDZ-AuNP colorimetric assay is capable of
distinguishing between DENV-2 NGC and CHIKV
(Figure 7), two symptomatically related viral pathogens,
and indicates the utility of this detection approach in
regions of the world that are endemic to both DENV
and CHIKV [63-65]. This increases the attractiveness
and utility of the assay in epidemiological surveillance of
dengue viruses in regions that are endemic to multiple
pathogens that display similar symptoms. UV/Vis spec-
trophotometric analysis of these samples showed a fifty
fold decrease in absorbance at 520 nm in the presence of
DENV, demonstrating our DENV detection method has
the sensitivity required for use with a spectrophotometer.
This DDZ-AuNP system allows for visual detection of
DENV at titers as low as 101/mL, which translates to
a concentration of 0.06nM DENV RNA (Figure 8A).
This compares quite favorably to a previously reported
RNA aptazyme-AuNP system that exhibits a sensitivity
of 7.5nM [62]. Further assessment of the limits of
DENV detection by UV/Vis spectrophotometric ana-
lysis (Figure 8B) demonstrates this assay displays sensi-
tivity that is consistent with previous reports of RNA
detection at sub-femtomole levels using gold nanoparti-
cle detection systems [72,73]. Though detection of
DENV RNAs at this low concentration is not physiolo-
gically relevant to what is present in posquitoes or
humans, our ability to detect al this level demonstrates
the power of AuNPs in detection schemes.
Moreover, despite the fact that we are detecting 1 × 106
TCID50 units, there are substantially more inactive virus
particles present in a given sample [77,78]. Therefore, by
adding SDS to lyse DENV particles the sensitivity of our
DDZ-AuNP detection method is enhanced for real
world applications. DENV infected patients exhibit ti-
ters of 107 to 108.5 TCID50 units [79]. Since we can de-
tect approximately 6 to 7 orders of magnitude or more
below this, our assay could potentially allow detection
of DENV in infected patients prior to the manifestation
of symptoms. Current DENV detection methods lack
consistent bedside detection of DENV prior to the
manifestation of symptoms [80], a caveat of NS-1 anti-
gen detection methods [81]. Secondly, individual Ae.
aegypti mosquitoes are typically infected at a titer of 101
to 102 TCID50 units [82], well within the limits of detec-
tion for this assay, making it potentially ideal for sur-
veillance of DENV in mosquito populations.
We have to date demonstrated that our multi-DENV
serotype detecting DDZ-M-AuNP device can detect all
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out sample processing (Figure 7E). Furthermore, serotype-
specific DDZ-tethered AuNPs have demonstrated utility
in detecting each of the corresponding four DENV sero-
types in a serotype specific manner (Figure 7E). For
example, DDZ-1 tethered AuNPs detected the presence of
DENV-1, and only the DENV-1 serotype, due to the
designed specificity of the DDZ-1 DNAzyme to a region
in the DENV-1 Capsid gene that is fully conserved solely
among the DENV-1 serotype. The other serotype specific
DDZ-tethered AuNPs possess this same feature in the de-
tection of their corresponding DENV serotype (Figure 7E,
see results summarized in Table 1). Full development of
this system will provide a valuable method for the detec-
tion of DENV in a serotype specific manner in mosquito
populations leading to enhanced speed and accuracy of
epidemiological surveillance.
The DDZ-AuNP assay’s simplicity provides distinct ad-
vantages over other virus detection methods. The assay
can be packaged as a pre-mixed reaction solution in
eppendorf tubes, and may be performed without any spe-
cialized equipment or training. Furthermore, this assay is
inexpensive, costing about $0.80 per sample, as compared
to serological testing or PCR-based methods which can
cost $2 per sample or more to perform. Assay compo-
nents are stable for months at room temperature [83], and
exhibit stability at temperatures greater than 30°C.
We anticipate further development of this assay will en-
able sensitive detection and discrimination of individual
DENV serotypes in mosquito populations and patient de-
rived samples as well as other virus derived RNAs. Detec-
tion prior to the onset of symptoms could allow more
effective diagnosis and treatment of infected patients, and
more rapid recovery from the disease. The simplicity of
the assay makes it ideal as a means of early surveillance to
target locations for more effective mosquito suppression
strategies.
Conclusions
The results presented here show that the DDZ-M-AuNP,
designed to be active against all forms of dengue virus,
is capable of effectively detecting the DENV 2-NGC gen-
ome in a sequence specific manner. Serotype specific
DNAzymes tethered to AuNPs demonstrate utility in the
independent identification of DENV serotypes. Coupling
DNAzyme catalysis with gold nanoparticle aggregation
provides an attractive alternative to other DENV detec-
tion approaches for the identification of DENV in
transformed mosquito cells and tissues.
Methods
DNAzyme, RNAprobe and AuNP
Thiol-modified and unmodified DNAzymes were synthe-
sized and desalted by Life Science Technologies (GrandIsland, NY, USA). The oligoribonucleotide target was syn-
thesized and HPLC-purified by Life Science Technologies.
Quantification of these oligonucleotides was performed
with the ND-1000 spectrophotometer from NanoDrop
(Wilmington, DE). Gold colloidal solutions containing
1.6 × 1012 particles/mL gold nanoparticles (AuNPs) with a
diameter of 15 nm were purchased from Cytodiagnostics
(Burlington, ON, CA).
Cells, virus and antibody
Ae. albopictus C6/36 cells were obtained from ATCC,
and maintained in Leibovitz’s L-15 media (Atlanta
Biologicals) supplemented with 10% FBS (Atlanta Biologi-
cals), 10% TPB (triptose phosphate broth; Invitrogen/
Gibco), penicillin G (100 U/ml; Invitrogen/Gibco) and
streptomycin (100 U/ml; Invitrogen/Gibco). The C6/36
cells used in this study were maintained in a 28°C incuba-
tor and passaged every 4 days. Viral stocks were prepared
as previously described [78].
The DENV strains and Genbank GenInfo identifiers for
the four serotypes used in this study are as follows: DENV
type 1 Hawaii: DQ672564.1, DENV type 2 strain New
Guinea C (NGC): AF038403.1, DENV type 3 strain ThD3
0010 87(strain H87): AY676352.1, DENV 4 strain DENV-
4/SG/06K2270DK1/2005 (strain H241): GQ398256.1.
Design of the anti-DENV DNAzyme (DDZ) and catalytically
inactive form (DDZin)
DENV sequence data was obtained from the national
center of biotechnology information (NCBI). Sequences
representative of all four serotypes of dengue were
aligned using ClustalX [54,55]. The aligned sequences
comprise the following genbank GenInfo identifiers:
12018173, 12018169, 12018171, 12659201, 2909798,
2909788, 2909786, 2909796, 6841603, 6841595, 6841605,
6841591, 6841601, 6841597, 6841593, 6841599, 6841587,
6841585, 6841589, 1000740, 1000738, 2909784, 1000736,
4926937, 4926935, 4926927, 4926929, 4926931, 2909794,
2909792, 1000742, 4926933, 2155257, 2723944, 323447,
6581076, 6581078, 2723942, 323449, 323650, 18644123,
1864412, 11119731, 19744844, 18644125, 18644127,
18643733, 4337012, 13386495, 1881708, 19071809,
13926152, 9280544, 14585842, 4926947, 4926939,
323654, 4926945, 4926943, 7329983, 7329981, 13540386,
14328931, 14485523, 323660, 17129645, 22901065,
22901063, 22901061, 1854040, 1854038, 1854036,
17129647, 24417519, 24417517, 24417515, 27656962,
24417513, 19071807, 14195698, 8927332, 14328929,
12711599, 323468, 25992053, 25992047, 25992041,
25992029, 25992025, 25992055, 25992033, 19071811,
25992043, 25992039, 25992037, 25992051, 25992031,
and 25992057.
The 5’ arms of DDZ-M and DDZin-M (Table 2) were
designed to bind to nucleotides 150 to 158 of the DENV
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end of the target region of the DENV genome that cor-
responds to nucleotides 140 to 148. These 5’ and 3’ arms
of facilitated DDZ cleavage of the substrate DENV RNA
between the purine-pyrimidine dinucleotide motifs G149
and C150.
The DDZ target site was selected by scanning the 5’CS
domain for one of the purine-pyrimidine dinucleotide
motifs required for DNAZyme catalysis [36]. The pri-
mary criterion for selection was that a purine-pyrimidine
motif located within the target site must be present in
all strains of a given DENV serotype. Another important
criterion for selecting suitable sites for DDZ cleavage
was that the length of conserved flanking arms be long
enough to insure specificity of the DNAzyme for the tar-
get site. The 5’ and 3’ arms of each DDZ were 9 bases in
length since this was determined to be optimal for
DNAzyme catalysis and provides a sufficient level of
specificity to insure minimal off-target effects [36].Preparation of DDZ-tethered AuNP (DDZ-AuNP)
Preparation of DDZ-M-AuNP was performed as previ-
ously described [83] with a few modifications. The
DTT-reduced thiol-DDZ-M 5’-SH-(CH2)6-d(TTTCTCT
CGGGCTAGCTACAACGAGTTTCAGCA)-3’ (SH-DD
Z-M) was purified by ethanol precipitation. 3 ml of AuNP
and 5 mM acetate buffer (pH 5.2) were transferred to a
glass scintillation vial, capped and incubated for 24 hours at
room temperature. Following incubation 5 mM Tris acetate
(pH 8.2) buffer and 100 mM NaCl were added and the
resulting mixture was incubated at room temperature for
an additional 24 hours. These functionalized particles
(500 μl) were transferred into 1.7-ml microcentrifuge tubes
and centrifuged at 16,110 g at room temperature for 15 min
to remove unreacted SH-DDZ-M. The nanoparticles were
redispersed in 1 mL of buffer containing 100 mM NaCl,
25 mM Tris acetate, (pH 8.2) and 0.01% SDS, centrifuged
again at 16,110 g at room temperature for 15 min. TheTable 2 Nucleotide sequences of active and negative control








Left column lists the active (DDZ-M) and inactive (DDZin-M) DNAzymes used in this
binding arms of the catalytically active DNAzymes and the inactive DDZin-M, respe
The right column lists the nucleotide sequence each binding arm binds to where a
description of DNAzyme design.supernatant was removed and the nanoparticles were dis-
persed in 500 μl of buffer containing 300 mM NaCl and
25 mM Tris acetate (pH 8.2), and re-centrifuged for
15 min to remove the remaining unreacted SH-DDZ-M.
The cleaned DDZ-M-AuNP were redispersed into 200 μL
of buffer containing 100 mM NaCl, 25 mM Tris acetate,
(pH 8.2) and 0.05% SDS. This same procedure was
followed for the coupling of DENV serotype-specific
DTT-reduced DNAzymes: thiol-DDZ-1 5’-SH-(CH2)6-d
(AGCCAxAAAGGCTAGxCTACAACGATCCTGCTG)-3’
(SH-DDZ-1), thiol-DDZ-2 5’-SH-(CH2)6- d(AAGGCGTA
GGCTAGCTACAACGATTCTCGCC)-3’ (SH-DDZ-2),
thiol-DDZ-3 5’-SH-(CH2)6-d(AGCCAAGAGGCTAGC
TACAACGATCCTGCTG)-3’ (SH-DDZ-3), and thiol
DDZ-4 5’-SH-(CH2)6-d(TTGGTTCGGCTAGCTACA
ACGATTTTCCAG)-3’ (SH-DDZ-4).Analysis of DDZ-tethered AuNPs in detecting a synthetic
DENV-2 artificial target
DDZ-AuNPs (1 × 105/mL) were combined in a 1.5 mL
eppendorff tube with 10 mM MgCl2 for optimal
DNAzyme activity [36], 1.0 M NaCl to drive aggregation
of AuNPs [30,51,58], and synthetic DENV-2 RNA target
(7.5 nM) corresponding to the 5’ 170 nucleotides of the
virus genome was added. Reaction mixes were incubated
at 37°C and inspected every 5 minutes over a 30 minute
period. Photographs were taken with a Nikon CoolPix
S3300 camera (Nikon USA, Melville, NY).Measurement of Mg2+ resistance of oligonucleotide-
tethered AuNPs
This analysis was performed as previously described
[30]. A mixture composed of 1 μL of DDZ-tethered
AuNPs, 50 mM Tris–HCl (pH 7.5), and increasing con-
centrations of MgCl2 (5 mM to 20 mM) 10 μL were in-
cubated at room temperature for 0 ~ 30 min. Photos of









report. The second and thrid columns list the sequences of the 5’and 3’
ctively. Also shown are the sequences of the catalytic cores of each DNAzyme.
pplicable. All sequences are displayed in a 5’ to 3’ direction. See Methods for
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measured with a ND-1000 spectrophotometer.In vitro analysis of DDZ-tethered AuNPs
DENV RNA was isolated from DENV infected Ae.
albopictus C6/36 cells using the QiaAmp viral RNA Mini
Kit (Qiagen) according to the manufacturer’s protocol.
10 μM of eluted DENV RNA was incubated with 1 × 105
DDZ-AuNP/ml for 30 min at 37°C. 15 ul of this reaction
mixture was added to a RT-PCR mix (Life Science Tech-
nologies) containing heterologous and random hexametric
primers to amplify the digested fragments. These RT-PCR
fragments were then separated on 1.75% agarose gels.Sodium dodecyl sulfate (SDS) titration analysis
Ten microliters (10 μl) of cell suspension containing
1 × 106 DENV-2 NGC/mL, as determined by TCID50-IFA,
was added to a mixture containing 150 mM Tris–HCl
(pH 7.5), 10 mM 10 mM MgCl2, 1 × 10
5 DDZ-AuNP par-
ticles/mL, 1.5 M NaCl and SDS at concentrations ranging
from 0% to 1% (w/v). Samples were incubated at 37°C for
30 minutes and analyzed every 5 min by visual inspection
for aggregation of AuNPs, an indicator of positive detec-
tion of in cell culture DENV-2. Photographs were taken
with a Nikon CoolPix S3300 camera.NaCl titration assay
DENV -2 NGC RNA were isolated from Aedes
albopictus C6/36 cells using the Qiamp Viral RNA mini
kit, and added at a concentration of 0.6 μM (~10μL) to a
reaction mixture containing 150 mM Tris–HCl (pH 7.5),
10 mM 10 mM MgCl2, 1 × 10
5 DDZ-AuNP particles/
mL, 0.5% (w/v) SDS, and NaCl (0 M to 2 M). Mixes
were incubated at 37°C for 30 minutes and analyzed
every 5 min by visual inspection for aggregation of
AuNPs. Samples were analyzed by visual inspection, and
photographs taken. Positive detection of DENV-2 NGC
RNAs was evident with a complete red to clear color
transition occurring with the addition of 1.5 M NaCl.Determination of DDZ-AuNP specificity
Ten microliters (10 uL) of cell culture fluid containing
1 × 106/mL DENV-2 NGC or, as a negative control,
CHIKV vaccine strain 181/25 [84] was added to a mix-
ture containing 150 mM Tris–HCl (pH 7.5), 10 mM
10 mM MgCl2, 1 × 10
5 DDZ-M-AuNP,DDZin-M-AuNP
or any of the serotype-specific DDZ tethered AuNPs/
mL, 0.5% (w/v) SDS, and 1.5 M NaCl. Samples were
mixed and incubated at 37°C for 5 minutes, photographs
were taken using the Nikon CoolPix S3300 camera, and
spectrophotometric analysis was performed using the
ND-1000 spectrophotometer.Analysis of DDZ-AuNP limits of DENV detection
DENV-2 NGC of the titers indicated (Figure 8) were
produced as follows. A titer of 1 × 106/mL was obtained
following inoculation of Ae. albopictus C6/36 cells with
0.1 MOI and incubated at 28°C for 6dpi. DENV-2 NGC
were grown to titers of 1 × 104/mL and 1 × 102/mL at
3dpi and 6dpi, respectively, following inoculation of
Vero cells with MOI of 0.1. DENV-2 NGC at a titer of
1 × 101/mL were produced by serial dilution of the 1 ×
102/mL stock. Titers were determined by TCID50-IFA as
described [53,66].
The DENV-2 NGC titers described above served as
substrates for DDZ-AuNP colorimetric assays to deter-
mine their limits of DENV detection. Ten microliters
(10 μl) of each dilution stock was added to a buffered re-
action mix containing 150 mM Tris–HCl (pH 7.5),
10 mM 10 mM MgCl2, 1 × 10
5 DDZ-M-AuNP particles/
mL, 1.5 M NaCl, and 0.5% (w/v) SDS. Samples were
mixed and incubated at 37°C for 5 minutes and photo-
graphs were taken Nikon CoolPix S3300 camera. UV/
Vis spectrophotometric analysis was performed using
the ND-1000 spectrophotometer.
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